• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种针对多重耐药革兰氏阴性杆菌的γ-内酰胺类铁载体抗生素。

A γ-Lactam Siderophore Antibiotic Effective against Multidrug-Resistant Gram-Negative Bacilli.

机构信息

Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio 44106, United States.

Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio 44106, United States.

出版信息

J Med Chem. 2020 Jun 11;63(11):5990-6002. doi: 10.1021/acs.jmedchem.0c00255. Epub 2020 Jun 2.

DOI:10.1021/acs.jmedchem.0c00255
PMID:32420736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7590959/
Abstract

Treatment of multidrug-resistant Gram-negative bacterial pathogens represents a critical clinical need. Here, we report a novel γ-lactam pyrazolidinone that targets penicillin-binding proteins (PBPs) and incorporates a siderophore moiety to facilitate uptake into the periplasm. The MIC values of γ-lactam YU253434, , are reported along with the finding that is resistant to hydrolysis by all four classes of β-lactamases. The druglike characteristics and mouse PK data are described along with the X-ray crystal structure of binding to its target PBP3.

摘要

治疗多重耐药革兰氏阴性菌病原体是一项重要的临床需求。在这里,我们报告了一种新型的γ-内酰胺吡唑烷酮,它靶向青霉素结合蛋白(PBPs)并包含一个铁载体部分,以促进进入周质。报告了γ-内酰胺 YU253434 的 MIC 值,并且发现 对所有四类β-内酰胺酶的水解均具有抗性。描述了药物特征和小鼠 PK 数据,以及与靶标 PBP3 结合的 的 X 射线晶体结构。

相似文献

1
A γ-Lactam Siderophore Antibiotic Effective against Multidrug-Resistant Gram-Negative Bacilli.一种针对多重耐药革兰氏阴性杆菌的γ-内酰胺类铁载体抗生素。
J Med Chem. 2020 Jun 11;63(11):5990-6002. doi: 10.1021/acs.jmedchem.0c00255. Epub 2020 Jun 2.
2
A γ-lactam siderophore antibiotic effective against multidrug-resistant Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter spp.一种 γ-内酰胺类铁载体抗生素,对多重耐药铜绿假单胞菌、肺炎克雷伯菌和不动杆菌属有效。
Eur J Med Chem. 2021 Aug 5;220:113436. doi: 10.1016/j.ejmech.2021.113436. Epub 2021 Apr 8.
3
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.头孢地尔:一种具有抗碳青霉烯类和多药耐药革兰氏阴性杆菌活性的铁载体头孢菌素。
Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2.
4
Structural Characterization of Diazabicyclooctane β-Lactam "Enhancers" in Complex with Penicillin-Binding Proteins PBP2 and PBP3 of Pseudomonas aeruginosa.与铜绿假单胞菌青霉素结合蛋白 PBP2 和 PBP3 复合物中二氮杂二环辛烷 β-内酰胺“增强剂”的结构特征。
mBio. 2021 Feb 16;12(1):e03058-20. doi: 10.1128/mBio.03058-20.
5
Structural Insights into Ceftobiprole Inhibition of Pseudomonas aeruginosa Penicillin-Binding Protein 3.结构洞察头孢妥仑匹罗对铜绿假单胞菌青霉素结合蛋白 3 的抑制作用。
Antimicrob Agents Chemother. 2020 Apr 21;64(5). doi: 10.1128/AAC.00106-20.
6
WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones.WCK 5107(齐德巴坦)和WCK 5153是新型PBP2抑制剂,对铜绿假单胞菌表现出强大的“β-内酰胺增强剂”活性,包括产多重耐药金属β-内酰胺酶的高风险克隆株。
Antimicrob Agents Chemother. 2017 May 24;61(6). doi: 10.1128/AAC.02529-16. Print 2017 Jun.
7
Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam.临床上相关的革兰氏阴性耐药机制对新型铁载体结合单氨卡巴的疗效没有影响。
Antimicrob Agents Chemother. 2012 Dec;56(12):6334-42. doi: 10.1128/AAC.01345-12. Epub 2012 Oct 1.
8
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug-Resistant Gram-Negative Pathogens.头孢地尔:一种新型的针对多重耐药革兰氏阴性病原体的铁载体头孢菌素。
Pharmacotherapy. 2020 Dec;40(12):1228-1247. doi: 10.1002/phar.2476. Epub 2020 Nov 19.
9
Design and synthesis of bridged gamma-lactams as analogues of beta-lactam antibiotics.作为β-内酰胺抗生素类似物的桥连γ-内酰胺的设计与合成。
Bioorg Med Chem Lett. 2004 May 17;14(10):2489-92. doi: 10.1016/j.bmcl.2004.03.004.
10
Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria.利用特定铁摄取途径进入细菌的新型铁载体 - β - 内酰胺缀合物的作用模式和抑制活性。
Antimicrob Agents Chemother. 1992 Oct;36(10):2166-75. doi: 10.1128/AAC.36.10.2166.

引用本文的文献

1
Structural basis of penicillin binding protein 3 inhibition by the siderophore-antibiotic cefiderocol.铁载体抗生素头孢地尔对青霉素结合蛋白3的抑制作用的结构基础
Chem Sci. 2024 Sep 18;15(41):16928-37. doi: 10.1039/d4sc04937c.
2
Enhancement of growth media for extreme iron limitation in Escherichia coli.用于大肠杆菌中极端铁限制的生长培养基的改良
Access Microbiol. 2024 Jun 3;6(6). doi: 10.1099/acmi.0.000735.v4. eCollection 2024.
3
Novel analogues of a nonnucleoside SARS-CoV-2 RdRp inhibitor as potential antivirotics.一种非核苷类新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)RNA依赖性RNA聚合酶(RdRp)抑制剂类似物作为潜在抗病毒药物
Beilstein J Org Chem. 2024 May 6;20:1029-1036. doi: 10.3762/bjoc.20.91. eCollection 2024.
4
Penicillin-binding protein (PBP) inhibitor development: A 10-year chemical perspective.青霉素结合蛋白(PBP)抑制剂的开发:十年的化学视角。
Exp Biol Med (Maywood). 2023 Oct;248(19):1657-1670. doi: 10.1177/15353702231208407. Epub 2023 Nov 29.
5
Siderophore conjugates to combat antibiotic-resistant bacteria.用于对抗抗生素耐药菌的铁载体结合物。
RSC Med Chem. 2023 Mar 1;14(5):800-822. doi: 10.1039/d2md00465h. eCollection 2023 May 25.
6
Identification of Penicillin Binding Protein 4 (PBP4) Inhibitors.青霉素结合蛋白4(PBP4)抑制剂的鉴定
Antibiotics (Basel). 2022 Oct 4;11(10):1351. doi: 10.3390/antibiotics11101351.
7
Structural analysis of the boronic acid β-lactamase inhibitor vaborbactam binding to Pseudomonas aeruginosa penicillin-binding protein 3.硼替佐米 β-内酰胺酶抑制剂瓦博巴坦与铜绿假单胞菌青霉素结合蛋白 3 的结构分析。
PLoS One. 2021 Oct 15;16(10):e0258359. doi: 10.1371/journal.pone.0258359. eCollection 2021.
8
A γ-lactam siderophore antibiotic effective against multidrug-resistant Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter spp.一种 γ-内酰胺类铁载体抗生素,对多重耐药铜绿假单胞菌、肺炎克雷伯菌和不动杆菌属有效。
Eur J Med Chem. 2021 Aug 5;220:113436. doi: 10.1016/j.ejmech.2021.113436. Epub 2021 Apr 8.
9
Advances in Understanding of the Copper Homeostasis in .铜代谢平衡研究进展
Int J Mol Sci. 2021 Feb 19;22(4):2050. doi: 10.3390/ijms22042050.
10
Structural Characterization of Diazabicyclooctane β-Lactam "Enhancers" in Complex with Penicillin-Binding Proteins PBP2 and PBP3 of Pseudomonas aeruginosa.与铜绿假单胞菌青霉素结合蛋白 PBP2 和 PBP3 复合物中二氮杂二环辛烷 β-内酰胺“增强剂”的结构特征。
mBio. 2021 Feb 16;12(1):e03058-20. doi: 10.1128/mBio.03058-20.

本文引用的文献

1
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.2015 年欧盟及欧洲经济区因抗生素耐药菌感染导致的死亡人数和伤残调整生命年:基于人群的模型分析。
Lancet Infect Dis. 2019 Jan;19(1):56-66. doi: 10.1016/S1473-3099(18)30605-4. Epub 2018 Nov 5.
2
Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV.快速分子诊断有助于经验性使用头孢他啶/阿维巴坦和头孢洛扎/他唑巴坦治疗铜绿假单胞菌:PRIMERS IV。
Clin Infect Dis. 2019 May 17;68(11):1823-1830. doi: 10.1093/cid/ciy801.
3
TonB-Dependent Receptor Repertoire of Pseudomonas aeruginosa for Uptake of Siderophore-Drug Conjugates.铜离子依赖型受体在铜绿假单胞菌摄取铁载体-药物偶联物中的作用。
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.00097-18. Print 2018 Jun.
4
A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant .一项关于耐碳青霉烯类皮肤和软组织感染的流行病学、管理及结局的前瞻性观察研究
Open Forum Infect Dis. 2017 Jul 27;4(3):ofx157. doi: 10.1093/ofid/ofx157. eCollection 2017 Summer.
5
Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including Carbapenem-Nonsusceptible Isolates (SIDERO-WT-2014 Study).头孢菌素类铁载体头孢地尔的活性对来自北美和欧洲的近期临床相关革兰氏阴性杆菌的收集,包括耐碳青霉烯类分离株(SIDERO-WT-2014 研究)。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00093-17. Print 2017 Sep.
6
Bacterial Iron Uptake Pathways: Gates for the Import of Bactericide Compounds.细菌铁摄取途径:杀菌化合物的入口。
J Med Chem. 2017 Jun 8;60(11):4573-4576. doi: 10.1021/acs.jmedchem.7b00554. Epub 2017 Apr 28.
7
Siderophores in Iron Metabolism: From Mechanism to Therapy Potential.铁代谢中的铁载体:从作用机制到治疗潜力
Trends Mol Med. 2016 Dec;22(12):1077-1090. doi: 10.1016/j.molmed.2016.10.005. Epub 2016 Nov 4.
8
Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa.铁载体头孢菌素头孢地尔利用铁转运系统对铜绿假单胞菌发挥抗菌活性。
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7396-7401. doi: 10.1128/AAC.01405-16. Print 2016 Dec.
9
Analysis of β-Lactamase Resistance Determinants in Enterobacteriaceae from Chicago Children: a Multicenter Survey.芝加哥儿童肠杆菌科细菌β-内酰胺酶耐药决定因素分析:一项多中心调查
Antimicrob Agents Chemother. 2016 May 23;60(6):3462-9. doi: 10.1128/AAC.00098-16. Print 2016 Jun.
10
Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II.快速分子诊断、抗生素治疗决策以及为经验性治疗提供信息的发展方法:引物I和II
Clin Infect Dis. 2016 Jan 15;62(2):181-9. doi: 10.1093/cid/civ837. Epub 2015 Sep 25.